Minnesota artist's work conveys what life is like with a chronic illness
Post-Bulletin,
Artist Drew Maude-Griffin, who suffers from the chronic fatigue syndrome, tries to curate care and comfort with work that will…
Showing items 1–100
What long Covid can tell us about post-infectious conditions
The Hindu,
By Ryan Prior In the early months of 2020 as Covid swept the world, I was a science writer with a mandate to tell the human…
Lesiones por vacunas contra COVID-19 y COVID prolongado: ¿Cuál es la diferencia?
Lagranepoca.com,
¿Cuál es la diferencia entre COVID prolongado y lesión por vacuna? Imagen editada por The Epoch Times (Pexels/ Nataliya…
Long COVID and COVID-19 Vaccine Injuries: What's the Difference?
The Epoch Times,
The COVID-19 pandemic is almost over—at least, officially. Yet many long-haulers and the vaccine-injured see no end in sight as…
The military is trying to learn more about long COVID. Troops who have it worry about their careers.
St Louis Public Radio,
Kara Gormont is the former Chief of Staff for the Defense Health Agency. She dedicated her career to helping keep service…
Identifying who has long COVID in the USA: a machine learning approach using N3C data
The Lancet,
BackgroundPost-acute sequelae of SARS-CoV-2 infection, known as long COVID, have severely affected recovery from the COVID-19…
Long COVID another ME/Chronic Fatigue Syndrome?
Medium US,
May 15 4 min read If so, we need to support for the millions of people suffering.
The military is trying to learn more about long COVID. Troops who have it worry about their careers.
KPBS,
Kara Gormont is the former Chief of Staff for the Defense Health Agency. She dedicated her career to helping keep service…
Little known of long COVID leaves Alberta patients seeking help | Globalnews.ca
Global News,
Walking up a single flight of stairs leaves Charlise Bruchet with sore legs. Walking at a brisk pace leaves her out of breath.
The military is trying to learn more about long COVID. Troops who have it worry about their careers.
WUNC,
Kara Gormont is the former Chief of Staff for the Defense Health Agency. She dedicated her career to helping keep service…
First Wave BioPharma Files U.S. and PCT …
TMCnet.com,
BOCA RATON, Fla., March 28, 2022 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First Wave BioPharma” or the “C…
First Wave BioPharma Files U.S. and PCT Patent Applications for Niclosamide in Long-Haul COVID-19
Biz Wire Express,
GlobeNewswire 2022-03-28 BOCA RATON, Fla., March 28, 2022 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First…
First Wave BioPharma Files U.S. and PCT Patent Applications for Niclosamide in Long-Haul COVID-19
Stockwatch,
BOCA RATON, Fla., March 28, 2022 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ:FWBI), ("First Wave BioPharma" or the "C…
First Wave BioPharma Files U.S. and PCT Patent Applications for Niclosamide in Long-Haul COVID-19
MarketScreener,
BOCA RATON, Fla., March 28, 2022 (GLOBE NEWSWIRE) --, (NASDAQ:FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage…
First Wave BioPharma Files U.S. and PCT Patent Applications for Niclosamide in Long-Haul COVID-19
Morning Star,
BOCA RATON, Fla., March 28, 2022 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First Wave BioPharma” or the “C…
First Wave BioPharma Files U.S. and PCT Patent Applications for Niclosamide in Long-Haul COVID-19
Benzinga,
BOCA RATON, Fla., March 28, 2022 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., FWBI, ("First Wave BioPharma" or the "Company")…
First Wave BioPharma Files U.S. and PCT Patent Applications for Niclosamide in Long-Haul COVID-19
GlobeNewswire,
BOCA RATON, Fla., March 28, 2022 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First Wave BioPharma” or the “C…
First Wave BioPharma Files U.S. and PCT Patent Applications for Niclosamide in Long-Haul COVID-19
Yahoo!,
BOCA RATON, Fla., March 28, 2022 -- First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First Wave BioPharma” or the “Company”), a…
First Wave BioPharma Files U.S. and PCT Patent Applications for Niclosamide in Long-Haul COVID-19
Yahoo! Finance USA,
BOCA RATON, Fla., March 28, 2022 First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First Wave BioPharma” or the “Company”), a…
First Wave BioPharma Files U.S. and PCT Patent Applications for Niclosamide in Long-Haul COVID-19
Biospace,
BOCA RATON, Fla., March 28, 2022 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First Wave BioPharma” or the “C…
COVID-19 et grossesse : ce qu'il faut savoir
National Geographic,
En mars 2020, à peine de retour chez elle dans l’Utah après des vacances à Hawaï, Lisa O’Brien est tombée malade; un des tous…
How COVID-19 can harm pregnancy and reproductive health
National Geographic,
Lisa O’Brien fell ill just after arriving home in Utah following a Hawaiian vacation in March 2020.
Vermonters with long Covid still face barriers to care
Newsbreak,
Emma Pouech had recovered from Covid-19. It was October 2020, and the 34-year-old Lincoln resident had mostly returned to…
What Experts Know About ‘Long Covid’ and Who Gets It
Washington Post,
Most people who suffer from Covid-19 fully recover. Millions of other survivors find complete healing to be frustratingly…
What Experts Know About ‘Long Covid’ and Who Gets It
Bloomberg Quint,
(Bloomberg) -- Most people who suffer from Covid-19 fully recover. Millions of other survivors find complete healing to be…
First Wave BioPharma Completes Enrollment for Part 2 of RESERVOIR Phase 2 Trial Evaluating FW-COV in COVID-19-Related GI Infections
Biz Wire Express,
GlobeNewswire 2022-01-06 No Drug-Related SAEs Reported; Topline Data Expected 1H 2022 Part 2 of RESERVOIR Trial to Evaluate…
First Wave BioPharma Completes Enrollment for Part 2 of RESERVOIR Phase 2 Trial Evaluating FW-COV in COVID-19-Related GI Infections
TMCnet.com,
No Drug-Related SAEs Reported; Topline Data Expected 1H 2022 Part 2 of RESERVOIR Trial to Evaluate Efficacy of FW-COV, an Oral…
First Wave BioPharma Completes Enrollment for Part 2 of RESERVOIR Phase 2 Trial Evaluating FW-COV in COVID-19-Related GI Infections
MarketScreener,
No Drug-Related SAEs Reported; Topline Data Expected 1H 2022 Part 2 of RESERVOIR Trial to Evaluate Efficacy of FW-COV, an Oral…
First Wave BioPharma Completes Enrollment for Part 2 of RESERVOIR Phase 2 Trial Evaluating FW-COV in COVID-19-Related GI Infections
Yahoo! Finance USA,
No Drug-Related SAEs Reported; Topline Data Expected 1H 2022 Part 2 of RESERVOIR Trial to Evaluate Efficacy of FW-COV, an Oral…
First Wave BioPharma Completes Enrollment for Part 2 of RESERVOIR Phase 2 Trial Evaluating FW-COV in COVID-19-Related GI Infections
Morning Star,
No Drug-Related SAEs Reported; Topline Data Expected 1H 2022 Part 2 of RESERVOIR Trial to Evaluate Efficacy of FW-COV, an Oral…
First Wave BioPharma Completes Enrollment For Part 2 Of RESERVOIR Phase 2 Trial Evaluating FW-COV In COVID-19-Related GI Infections
The Street,
No Drug-Related SAEs Reported; Topline Data Expected 1H 2022 Part 2 of RESERVOIR Trial to Evaluate Efficacy of FW-COV, an Oral…
First Wave BioPharma Completes Enrollment for Part 2 of RESERVOIR Phase 2 Trial Evaluating FW-COV in COVID-19-Related GI Infections
GlobeNewswire,
No Drug-Related SAEs Reported; Topline Data Expected 1H 2022 Part 2 of RESERVOIR Trial to Evaluate Efficacy of FW-COV, an Oral…
First Wave BioPharma Completes Enrollment for Part 2 of RESERVOIR Phase 2 Trial Evaluating FW-COV in COVID-19-Related GI Infections
Yahoo!,
No Drug-Related SAEs Reported; Topline Data Expected 1H 2022 Part 2 of RESERVOIR Trial to Evaluate Efficacy of FW-COV, an Oral…
First Wave BioPharma Completes Enrollment for Part 2 of RESERVOIR Phase 2 Trial Evaluating FW-COV in COVID-19-Related GI Infections
Biospace,
No Drug-Related SAEs Reported; Topline Data Expected 1H 2022 Part 2 of RESERVOIR Trial to Evaluate Efficacy of FW-COV, an Oral…
Long Covid, è ancora mistero sullo sviluppo dei sintomi dopo l'infezione - Galileo
Galileonet,
Long Covid.Ovvero: un insieme di sintomi persistenti e disabilitanti di cui soffrono alcuni pazienti sopravvissuti aCovid-19.
First Wave BioPharma Announces Independent Data Monitoring Committee Provides Positive Interim Safety Assessment for Part 2 COVID-19 RESERVOIR Clinical Trial of Niclosamide for the Treatment of Gastrointestinal Infections
Biz Wire Express,
GlobeNewswire 2021-11-30 Review of Data from Initial 25 Patients Completed with Favorable Recommendation BOCA RATON, Fla., Nov.
First Wave BioPharma Announces Independent Data Monitoring Committee Provides Positive Interim Safety Assessment for Part 2 COVID-19 RESERVOIR Clinical Trial of Niclosamide for the Treatment of Gastrointestinal Infections
MarketScreener,
BOCA RATON, Fla., Nov. 30, 2021 (GLOBE NEWSWIRE) --, (NASDAQ:FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage…
First Wave BioPharma Announces Independent Data Monitoring Committee Provides Positive Interim Safety Assessment for Part 2 COVID-19 RESERVOIR Clinical Trial of Niclosamide for the Treatment of Gastrointestinal Infections
GlobeNewswire,
BOCA RATON, Fla., Nov. 30, 2021 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First Wave BioPharma” or the “Co…
First Wave BioPharma Announces Independent Data Monitoring Committee Provides Positive Interim Safety Assessment for Part 2 COVID-19 RESERVOIR Clinical Trial of Niclosamide for the Treatment of Gastrointestinal Infections
Yahoo! Finance USA,
Review of Data from Initial 25 Patients Completed with Favorable Recommendation BOCA RATON, Fla., Nov.
First Wave BioPharma Announces Independent Data Monitoring Committee Provides Positive Interim Safety Assessment for Part 2 COVID-19 RESERVOIR Clinical Trial of Niclosamide for the Treatment of Gastrointestinal Infections
Yahoo!,
Review of Data from Initial 25 Patients Completed with Favorable Recommendation BOCA RATON, Fla., Nov.
First Wave BioPharma Announces Independent Data Monitoring Committee Provides Positive Interim Safety Assessment for Part 2 COVID-19 RESERVOIR Clinical Trial of Niclosamide for the Treatment of Gastrointestinal Infections
Morning Star,
BOCA RATON, Fla., Nov. 30, 2021 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First Wave BioPharma” or the “Co…
First Wave BioPharma Announces Independent Data Monitoring Committee Provides Positive Interim Safety Assessment for Part 2 COVID-19 RESERVOIR Clinical Trial of Niclosamide for the Treatment of Gastrointestinal Infections
Biospace,
Review of Data from Initial 25 Patients Completed with Favorable Recommendation BOCA RATON, Fla., Nov.
To Help People With Long Covid, Scientists Need to Define It
Wired.com,
Maryn McKenna 11.24.2021 08:00 AMPatients with the perplexing syndrome have reported 200 different symptoms.
Long COVID: More Clues Coming, but No 'Aha' Moments Yet
WebMD News,
Nov. 12, 2021 -- In late April 2020, about 6 weeks after the pandemic was declared, physical therapist David Putrino was in a…
Long COVID: More Clues Coming, but No 'Aha' Moments Yet
Medscape,
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center.
Returning to Work: Millions in Uncharted Waters Due to Long-Haul COVID-19
Healthline ,
Share on PinterestMillions of people in the U.S. are dealing with the long-term effects of COVID-19.
AzurRx BioPharma Activates New Clinical Trial Sites in India for Phase 2 RESERVOIR Trial Evaluating Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections
FirstWord Pharma,
BOCA RATON, Fla., Sept. 10, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. ("AzurRx" or the "Company") (NASDAQ: AZRX), a…
AzurRx BioPharma Activates New Clinical Trial Sites in India for Phase 2 RESERVOIR Trial Evaluating Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections
Jotup,
FW-1022 is a proprietary oral tablet formulation of micronized niclosamide developed for the treatment of COVID-19-related GI…
AzurRx BioPharma Activates New Clinical Trial Sites in …
TMCnet.com,
BOCA RATON, Fla., Sept. 10, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a…
AzurRx BioPharma Activates New Clinical Trial Sites in India for Phase 2 RESERVOIR Trial Evaluating Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections
Biz Wire Express,
GlobeNewswire 2021-09-10 Phase 2 placebo-controlled clinical trial to confirm safety of FW-1022 and investigate its ability to…
AzurRx BioPharma Activates New Clinical Trial Sites in India for Phase 2 RESERVOIR Trial Evaluating Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections
MarketScreener,
BOCA RATON, Fla., Sept. 10, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a…
AzurRx BioPharma Activates New Clinical Trial Sites in India for Phase 2 RESERVOIR Trial Evaluating Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections
Stockwatch,
BOCA RATON, Fla., Sept. 10, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a…
AzurRx BioPharma Activates New Clinical Trial Sites in India for Phase 2 RESERVOIR Trial Evaluating Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections
Morning Star,
BOCA RATON, Fla., Sept. 10, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a…
AzurRx BioPharma Activates New Clinical Trial Sites In India For Phase 2 RESERVOIR Trial Evaluating Niclosamide For The Treatment Of COVID-19 Gastrointestinal Infections
The Street,
Phase 2 placebo-controlled clinical trial to confirm safety of FW-1022 and investigate its ability to remove SARS-CoV-2 virus…
AzurRx BioPharma Activates New Clinical Trial Sites in India for Phase 2 RESERVOIR Trial Evaluating Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections
Yahoo! Finance USA,
In this article: Phase 2 placebo-controlled clinical trial to confirm safety of FW-1022 and investigate its ability to remove…
AzurRx BioPharma Activates New Clinical Trial Sites in India for Phase 2 RESERVOIR Trial Evaluating Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections
GlobeNewswire,
BOCA RATON, Fla., Sept. 10, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a…
AzurRx BioPharma Announces Positive Results from Independent Data Monitoring Committee Review of Safety Data from Part 1 of RESERVOIR Phase 2 Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections
FirstWord Pharma,
Review of Interim Safety Data Concluded with Favorable Recommendation to Continue RESERVOIR Trial as Planned Part 2 of…
AzurRx BioPharma Announces Positive Results from Independent Data Monitoring Committee Review of Safety Data from Part 1 of RESERVOIR Phase 2 Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections
MarketScreener,
Review of Interim Safety Data Concluded with Favorable Recommendation to Continue RESERVOIR Trial as Planned Part 2 of…
AzurRx BioPharma Announces Positive Results from Independent Data Monitoring Committee Review of Safety Data from Part 1 of RESERVOIR Phase 2 Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections
Yahoo! Finance USA,
In this article: Review of Interim Safety Data Concluded with Favorable Recommendation to Continue RESERVOIR Trial as Planned…
Mechanisms of Long COVID Remain Unknown but Data Are Rolling In
The Scientist Magazine,
A year and a half into the pandemic, the long-term effects of SARS-CoV-2 infection are garnering more research attention as…
Infographic: Bodily Systems Affected by Long COVID
The Scientist Magazine,
Symptoms documented in cases of long COVID are wide ranging and variable.Infection with SARS-CoV-2 can lead to symptoms that…
Infographic: Bodily Systems Affected by Long COVID
Newsbreak,
Infection with SARS-CoV-2 can lead to symptoms that last for weeks, months, or even years, and scientists are only just…
News story from The Age on Sunday 22 August 2021
The Age,
News story from Sydney Morning Herald on Sunday 22 August 2021
Sydney Morning Herald,
Are the vaccinated at risk of long COVID if they get infected?
Brisbane Times,
By Tara Parker-Pope August 22, 2021 — 12.53pm New York: While some infections among those who are fully vaccinated against COVID…
News story from Western Australia Today on Sunday 22 August 2021
Western Australia Today,
Can the vaccinated develop long COVID after recovering from infection?
Channel News Asia CNA,
While some breakthrough cases among those who are fully vaccinated against COVID-19 are inevitable, they are unlikely to result…
Long-COVID: Alles, was Forscher bisher wissen
Medscape,
Wer unter Long-COVID leidet, zeigt meist anhaltende Symptome noch Wochen nach einer akuten Corona-Infektion, dazu gehören…
Can the Vaccinated Develop Long Covid After a Breakthrough Infection? - Times of India
Times of India,
While some breakthrough cases among those who are fully vaccinated against Covid-19 are inevitable, they are unlikely to result…
Explained: Can the vaccinated develop long Covid after a breakthrough infection?
The Indian Express,
While some breakthrough cases among those who are fully vaccinated against COVID-19 are inevitable, they are unlikely to result…
Can the vaccinated develop long COVID after a breakthrough infection?
Star Tribune,
There are still more questions than answers: "It's too early to tell." While some breakthrough cases among those who are fully…
Can the vaccinated develop long COVID after a breakthrough infection?
Star Advertiser,
While some breakthrough cases among those who are fully vaccinated against COVID-19 are inevitable, they are unlikely to result…
Can the Vaccinated Develop Long COVID After a Breakthrough Infection?
Yahoo!,
While some breakthrough cases among those who are fully vaccinated against COVID-19 are inevitable, they are unlikely to result…
Can the Vaccinated Develop Long COVID After a Breakthrough Infection?
Daily Magazine,
While some breakthrough cases among those who are fully vaccinated against COVID-19 are inevitable, they are unlikely to result…
Can the vaccinated develop long COVID after a breakthrough Infection?
bdnews24,
While some breakthrough cases among those who are fully vaccinated against COVID-19 are inevitable, they are unlikely to result…
Can the Vaccinated Develop Long Covid After a Breakthrough Infection?
New York Times,
While the vaccines are effective at preventing serious illness and death, the risk of developing post-Covid health problems…
Can the Vaccinated Develop Long Covid After a Breakthrough Infection?
DNYUZ,
While some breakthrough cases among those who are fully vaccinated against Covid-19 are inevitable, they are unlikely to result…
AzurRx BioPharma Completes Initial Cohort Enrollment into Part 1 of its RESERVOIR Phase 2 Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections
FirstWord Pharma,
BOCA RATON, Fla., Aug. 12, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. ("AzurRx" or the "Company") (NASDAQ: AZRX), a…
AzurRx BioPharma Completes Initial Cohort Enrollment into Part 1 of its RESERVOIR Phase 2 Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections
Biospace,
BOCA RATON, Fla., Aug. 12, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (), a company…
AzurRx BioPharma Completes Initial Cohort Enrollment into Part 1 of its RESERVOIR Phase 2 Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections
Biz Wire Express,
GlobeNewswire 2021-08-12 BOCA RATON, Fla., Aug. 12, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc.
AzurRx BioPharma Completes Initial Cohort Enrollment into Part 1 of its RESERVOIR Phase 2 Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections
TMCnet.com,
BOCA RATON, Fla., Aug. 12, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a…
AZURRX BIOPHARMA : Completes Initial Cohort Enrollment into Part 1 of its RESERVOIR Phase 2 Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections
MarketScreener,
BOCA RATON, Fla., Aug. 12, 2021 (GLOBE NEWSWIRE) --, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company specializing in…
AzurRx BioPharma Completes Initial Cohort Enrollment into Part 1 of its RESERVOIR Phase 2 Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections
GlobeNewswire,
BOCA RATON, Fla., Aug. 12, 2021 (GLOBE NEWSWIRE) --, Inc. (“AzurRx” or the “Company”) (), a company specializing in the…
AzurRx BioPharma Completes Initial Cohort Enrollment into Part 1 of its RESERVOIR Phase 2 Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections
Morning Star,
BOCA RATON, Fla., Aug. 12, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a…
AzurRx BioPharma Completes Initial Cohort Enrollment into Part 1 of its RESERVOIR Phase 2 Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections
Yahoo! Finance USA,
In this article: BOCA RATON, Fla., Aug. 12, 2021 AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company…
AzurRx BioPharma Completes Initial Cohort Enrollment Into Part 1 Of Its RESERVOIR Phase 2 Clinical Trial Of Niclosamide For The Treatment Of COVID-19 Gastrointestinal Infections
The Street,
BOCA RATON, Fla., Aug. BOCA RATON, Fla., Aug. 12, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc.
AzurRx BioPharma Adds New Clinical Trial Sites in Ukraine for Phase 2 RESERVOIR Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections
FirstWord Pharma,
BOCA RATON, Fla., Aug. 10, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. ("AzurRx" or the "Company") (NASDAQ: AZRX), a…
AzurRx BioPharma Adds New Clinical Trial Sites in Ukraine for Phase 2 RESERVOIR Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections
Jotup,
FW-1022 is a proprietary oral tablet formulation of micronized niclosamide developed for the treatment of COVID-19-related GI…
AzurRx BioPharma Adds New Clinical Trial Sites in Ukraine for Phase 2 RESERVOIR Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections
Biz Wire Express,
GlobeNewswire 2021-08-10 BOCA RATON, Fla., Aug. 10, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc.
AzurRx BioPharma Adds New Clinical Trial Sites in Ukraine for Phase 2 RESERVOIR Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections
TMCnet.com,
BOCA RATON, Fla., Aug. 10, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a…
AzurRx BioPharma Adds New Clinical Trial Sites in Ukraine for Phase 2 RESERVOIR Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections
Yahoo! Finance USA,
In this article: BOCA RATON, Fla., Aug. 10, 2021 AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company…
AzurRx BioPharma Adds New Clinical Trial Sites in Ukraine for Phase 2 RESERVOIR Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections
Morning Star,
BOCA RATON, Fla., Aug. 10, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a…
AzurRx BioPharma Adds New Clinical Trial Sites In Ukraine For Phase 2 RESERVOIR Clinical Trial Of Niclosamide For The Treatment Of COVID-19 Gastrointestinal Infections
The Street,
BOCA RATON, Fla., Aug. BOCA RATON, Fla., Aug. 10, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc.
AzurRx BioPharma Adds New Clinical Trial Sites in Ukraine for Phase 2 RESERVOIR Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections
GlobeNewswire,
BOCA RATON, Fla., Aug. 10, 2021 (GLOBE NEWSWIRE) --, Inc. (“AzurRx” or the “Company”) (), a company specializing in the…
Mengurai penyebab 'Covid panjang', dan bagaimana cara mengobatinya - BBC News Indonesia
BBC News,
30 menit yang lalu Sumber gambar, Getty Images Ketika Melissa Heightman membuka klinik pasca-Covid-19 pertama di Inggris pada…
International study identifies more than 200 long COVID symptoms
Healio.com,
July 30, 2021 4 min read Source/Disclosures Disclosures: Aiyegbusi reports receiving funding from Gilead Sciences, Innovate UK…
Article Life as a Long-Hauler: What Do We Know About Long COVID? In this honest account, science writer Leo Bear-McGuinness shares what it's like to live with long COVID as a "long-hauler", and explores how the condition has awakened an urgency in post-vi
Technology Networks,
I first learned about long COVID in August last year while reading an article. Back then, most people’s perspective on the…
Andy Larsen: We’re starting to demystify long COVID — what it means, who gets it, and what to do about it
The Salt Lake Tribune,
From a dizzying array of reported symptoms to the risk factors involved, researchers are starting to get a handle on the plight…
La lucha contra el COVID-19 prolongado no se detiene
infobae,
En muchos países, la pandemia por COVID-19 no muestra signos de disminuir y los sistemas de salud ya están en capacidad de…
I rested my way to recovery from long Covid. I urge others to do the same
MSN,
Within a few days of being discharged from the hospital in March last year, it was clear I was not improving in any sort of…
Showing items 1–100